Dr. Terri L. Fletcher, PhD
Claim this profileMichael E. DeBakey VA Medical Center, Houston, TX
Studies Anxiety Disorders
Studies Post-Traumatic Stress Disorder
4 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Terri L. Fletcher, PhD is currently running
Intensive CBT
for PTSD
The goal of this clinical trial is to compare two different intensive formats of delivering cognitive-behavioral treatment for people with PTSD and anxiety disorders. The main questions it aims to answer are: * Is iTCBT delivered in individual and group formats more effective than TAU in improving anxiety symptoms and quality of life? * For treatment non-responders, is iTCBT-Enhanced more effective than TAU improving anxiety symptoms and quality of life? * Does iTCBT-Individual produce a larger improvement in anxiety and quality of life compared with iTCBT-Group? Participants will undergo several assessments throughout the course of the study. Based on randomization, they will receive: (1) iTCBT in an individual format over a 2-week period, (2) iTCBT in a group format over a 2-day period, or (3) usual care. Those who do not show a response to treatment will receive 4 additional individual therapy sessions.
Recruiting1 award N/A
Exposure and Response Prevention
for Obsessive-Compulsive Disorder
This trial will test a therapy called ERP, which helps people face their fears and stop doing habits that make them feel temporarily better but keep the problem going. It will focus on Veterans with OCD, including those who also have PTSD. The goal is to see if this therapy improves their daily functioning and quality of life.
Recruiting1 award N/A1 criteria
More about Terri L. Fletcher, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Terri L. Fletcher, PhD has experience with
- Brief Cognitive Behavioral Therapy
- Exposure And Response Prevention
- Control
- EMBER
- ITCBT-G
- ITCBT-I
Breakdown of trials Terri L. Fletcher, PhD has run
Anxiety Disorders
Post-Traumatic Stress Disorder
Panic Disorder
Social Anxiety Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Terri L. Fletcher, PhD specialize in?
Terri L. Fletcher, PhD focuses on Anxiety Disorders and Post-Traumatic Stress Disorder. In particular, much of their work with Anxiety Disorders has involved treating patients, or patients who are undergoing treatment.
Is Terri L. Fletcher, PhD currently recruiting for clinical trials?
Yes, Terri L. Fletcher, PhD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Terri L. Fletcher, PhD has studied deeply?
Yes, Terri L. Fletcher, PhD has studied treatments such as Brief Cognitive Behavioral Therapy, Exposure and Response Prevention, Control.
What is the best way to schedule an appointment with Terri L. Fletcher, PhD?
Apply for one of the trials that Terri L. Fletcher, PhD is conducting.
What is the office address of Terri L. Fletcher, PhD?
The office of Terri L. Fletcher, PhD is located at: Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas 77030-4211 United States. This is the address for their practice at the Michael E. DeBakey VA Medical Center, Houston, TX.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.